home
RSS
FDA approves new drug for late-stage melanoma
March 25th, 2011
12:29 PM ET

FDA approves new drug for late-stage melanoma

The U.S. Food and Drug Administration has approved the first  melanoma  drug in 13 years. The new drug, ipilimumab, which will be sold under the brand name Yervoy and manufactured by Bristol-Myers Squibb, is designed to stop the cancer cells from growing by stimulating the immune system to recognize the cancer cells as something to attack.

"Late-stage melanoma is devastating, with very few treatment options for patients, none of which previously prolonged a patient's life," Richard Pazdur, M.D., director of the FDA's Office of Oncology Drug Products said in a press statement."Yervoy is the first therapy approved by the FDA to clearly demonstrate that patients with metastatic melanoma live longer by taking this treatment."

"It's good solid base hit, but it's not a home run," says Tim Turnham, executive director of the Melanoma Research Foundation. "The response rates are in the low 20% rate, so three-fourths of the people who take it won't benefit from it," Turnham says. "It's pretty clear we still have a long way to go."

FULL POST


Device could detect melanoma without cutting skin
November 19th, 2010
09:38 AM ET

Device could detect melanoma without cutting skin

Doctors may have a new tool for diagnosing the deadly skin cancer melanoma with cutting the skin,  after a Food and Drug Administration advisory committee on Thursday recommended approval of the device.

FULL POST


« newer posts
Advertisement
About this blog

Get a behind-the-scenes look at the latest stories from CNN Chief Medical Correspondent, Dr. Sanjay Gupta, Senior Medical Correspondent Elizabeth Cohen and the CNN Medical Unit producers. They'll share news and views on health and medical trends - info that will help you take better care of yourself and the people you love.

Advertisement
Advertisement